Direct proteolytic machine assessments for unfolding and sequencing proteins
Active Project Grant Awarded Last action
- Award ID
- R43GM159820
- Recipient
-
Electronic Biosciences, Inc. UEI FLHHE89XH2H5
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $350,000
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 69% complete
- Originally
- Place of performance
- Utah, USA
Award details come from USAspending.gov.
Description
- Abstract
- Protein sequencing is a cornerstone of proteomics, offering crucial insights into the molecular underpinnings of biological processes and diseases. However, current proteomic tools, such as mass spectrometry (MS), immunoassays, and protein cataloging approaches, are limited by high costs, low throughput, and an inability to perform comprehensive DE novo protein sequencing. These limitations hinder the accurate characterization of low-abundance proteins and the sequencing and quantification of post-translational modifications (ptms), single nucleotide polymorphisms (snps), and splicing variants, making proteome-wide analysis challenging. Given these constraints and the growing demand for more comprehensive proteomic analysis, there is a significant opportunity to develop more efficient, cost-effective, and scalable protein sequencing methods. In response, electronic biosciences, INC. (EBS) proposes to develop and demonstrate a novel enzyme-based, single- molecule protein sequencing system. This innovative platform will leverage enzyme-driven processing and sequencing of individual proteins and peptides, combined with advanced bioinformatics, to achieve high accuracy and throughput. During this phase i program, we will develop and optimize this single-molecule sequencing approach, demonstrating its ability to accurately sequence peptides with various ptms, surpassing the capabilities of current state-of-the-art methods. By integrating enzymatic assessments with sophisticated sequencing algorithms, our system aims to enable scalable, multiplexed protein sequencing, capable of analyzing all proteins and peptides in a given sample. Our proposed system will not only be rapid, reliable, and low-cost but also accessible for a wide range of applications, from basic research to clinical diagnostics. This technology has the potential to revolutionize protein analysis, facilitating rapid biomarker discovery and enhancing disease testing and monitoring, ultimately advancing biomedical research and public health.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $350,000 |
Quick answers
Who received award R43GM159820?
R43GM159820 was awarded to Electronic Biosciences, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on June 5, 2025.
How much is award R43GM159820 worth?
$350,000 has been obligated on R43GM159820.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award